featured
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study
J. Clin. Oncol 2015 Nov 02;[EPub Ahead of Print], T André, A de Gramont, D Vernerey, B Chibaudel, F Bonnetain, A Tijeras-Raballand, A Scriva, T Hickish, J Tabernero, JL Van Laethem, M Banzi, E Maartense, E Shmueli, GU Carlsson, W Scheithauer, D Papamichael, M Möehler, S Landolfi, P Demetter, S Colote, C Tournigand, C Louvet, A Duval, JF Fléjou, A de GramontFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.